DTC/DTP + Telemedicine – The Next Big Thing in Pharma?

How should pharma leaders adapt to this new DTC/DTP-driven world, and what role does telemedicine play in closing the loop from awareness to access?

DTC/DTP + Telemedicine: The Next Big Thing in Pharma?

Download Case Study Here.

Archbow Consulting recently partnered with Omnicom Health to raise awareness about a buzz-worthy case study examining the recent trend of Direct-to-Consumer (DTC) and Direct-to-Patient (DTP) models—and what these shifts mean for the future of the pharmaceutical industry.

Discover how DTC/DTP and telemedicine are transforming healthcare access. Dive into real-world insights on digital health solutions, improved patient outcomes, and the evolving landscape of care delivery. Read the full case study here.

For additional insights on this topic, you may also enjoy the following:

Significant Changes in Healthcare: Regulations in Law

Understanding Fair Market Value

Digital Solutions in Patient Services

Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn or subscribing to this blog which you can do below.

Share in